Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document C2011/213/11

    Prior notification of a concentration (Case COMP/M.6293 — Thermo Fisher/Phadia) Text with EEA relevance

    OJ C 213, 20.7.2011, p. 28–28 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    20.7.2011   

    EN

    Official Journal of the European Union

    C 213/28

    Prior notification of a concentration

    (Case COMP/M.6293 — Thermo Fisher/Phadia)

    (Text with EEA relevance)

    2011/C 213/11

    1.

    On 12 July 2011, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Thermo Fisher Scientific, Inc. (‘Thermo Fisher’, USA) acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of CB Diagnostics Holding AB, the holding company and sole owner of Phadia Holding AB (‘Phadia’, Sweden) by way of purchase of shares.

    2.

    The business activities of the undertakings concerned are:

    —

    Thermo Fisher: laboratory and life science instruments and related products, including in vitro diagnostics systems,

    —

    Phadia: immunodiagnostic blood test systems to support the clinical (in vitro) diagnosis and monitoring of allergy and autoimmune diseases.

    3.

    On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved.

    4.

    The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

    Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6293 — Thermo Fisher/Phadia, to the following address:

    European Commission

    Directorate-General for Competition

    Merger Registry

    J-70

    1049 Bruxelles/Brussel

    BELGIQUE/BELGIË

    (1)  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

    Top